首页|基于玄府理论探讨苍附导痰汤治疗痰浊闭阻型冠心病胸痛的临床研究

基于玄府理论探讨苍附导痰汤治疗痰浊闭阻型冠心病胸痛的临床研究

扫码查看
目的:基于玄府理论探讨苍附导痰汤治疗冠心病胸痛的临床疗效.方法:选择符合纳入标准的痰浊闭阻型冠心病胸痛患者153例,按照抛硬币随机分组法随机分为对照组75例和观察组78例.对照组给予常规西药干预,观察组在对照组的基础上口服苍附导痰汤,早晚各1次,两组患者疗程均为2周.比较两组患治疗前后N末端B型脑钠肽原(NT-proBNP)、肌钙蛋白(cTnI)、血压、中医症状评分(胸痛、心悸、气短)、胸痛发作次数及持续时间的变化情况,并比较两组临床疗效和不良反应发生情况.结果:治疗后,观察组治疗有效率(94.87%,74/78)高于对照组(84%,63/75),差异有统计学意义(P<0.05).治疗后,两组患者NT-proBNP、cTnI、收缩压、舒张压均降低(P<0.05),且观察组低于对照组(P<0.01).治疗后,两组心悸、胸痛、气短中医症状评分降低(P<0.05),且观察组低于对照组(P<0.01).两组治疗后胸痛发作次数及持续时间均减少(P<0.05),且观察组低于观察组(P<0.01).两组治疗过程中不良反应发生情况比较差异无统计学意义(P>0.05).结论:基于玄府理论采用苍附导痰汤治疗痰浊闭阻型冠心病胸痛疗效较好,可改善患者相关症状及心功能,且不良反应少.
A Randomized Controlled Study of Cangfu Daotan Decoction for Chest Pain in Patients with Coronary Heart Disease of Phlegm Turbid Obstruction Type Based on Xuanfu Theory
Objective:To explore the clinical efficacy of Cangfu Daotan Decoction(CDD)based on Xuanfu theory in treating chest pain of coronary heart disease.Methods:A total of 153 patients with chest pain in coronary heart disease(CHD)with phlegm turbid obstruction type meeting the inclusion criteria were randomly divided into control group(75 cases)and observation group(78 cases)according to coin toss randomization method.The control group was given conventional Western medicine intervention,and the observation group was given the same in addition to oral CDD,once in the morning and once in the evening.The course of treatment for both groups was 2 weeks.N-terminal probrain natriuretic peptide(NT-proBNP),cardiac troponin(cTnI),blood pressure,TCM syndrome scores(chest pain,palpitations,shortness of breath),frequency and duration of each chest pain and adverse reaction rate were compared between the two groups.Results:After treatment,the effective rate of the observation group(94.87%,74/78)was higher than that of the control group(84%,63/75),the difference was statistically significant(P<0.05).After treatment,NT-proBNP,cTnI,systolic blood pressure and diastolic blood pressure decreased in both groups(P<0.05),and the observation group was lower than the control group(P<0.01).After treatment,TCM symptom scores of palpitation,chest pain and shortness of breath decreased in both groups(P<0.05),and the observation group was lower than the control group(P<0.01),and the frequency and duration of chest pain decreased in both groups(P<0.05),and the observation group was lower than the observation group(P<0.01).There was no statistical significance in the occurrence of adverse reactions between the two groups(P>0.05).Conclusion:Based on Xuanfu theory,Cangfu Daotan Decoction is effective in treating chest pain of phlegm turbid obstruction type coronary heart disease.It can improve related symptoms and heart function of patients with less adverse reactions.

Xuanfu theoryCangfu Daotan DecoctionCoronary heart disease and chest pain

贾梦丽、娄政驰、张蕊、马国靖、王合垒、程刚、闫喜凤、王晨琳

展开 >

新乡医学院第三附属医院,河南 新乡 453000

延津县中医院,河南 新乡 453200

玄府理论 苍附导痰汤 冠心病胸痛

2021年全国基层名老中医药专家传承工作室建设项目

国中医药人教发函[2021]44号

2024

中医药信息
中华中医药学会,黑龙江中医药大学

中医药信息

影响因子:1.219
ISSN:1002-2406
年,卷(期):2024.41(1)
  • 18